Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Food Chem Toxicol ; 173: 113608, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36639049

ABSTRACT

Human exposure to persistent organic pollutants (POPs) may contribute to obesogenic effects. We have previously shown that POP mixtures modelled on blood levels relevant to the Scandinavian population induces adipogenic effects in the mouse 3T3-L1 cell line. Luteolin is a flavone that has shown anti-lipogenic and anti-adipogenic effects on adipogenesis in in vitro models. In this study, luteolin has been applied to inhibit adipocyte formation and intracellular lipid content increase induced by a human relevant mixture of POPs. 3T3-L1 cells were exposed to a POP mixture consisting of 29 chemicals, including amongst others polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs), perfluoroalkylated acids (PFAAs), and polybrominated diphenyl ethers (PBDEs). Rosiglitazone was applied as a positive lipogenic control. Luteolin was tested between 0.5 and 10 µM. High content analysis was used to assess changes in adipocyte formation and intracellular lipid content in the 3T3-L1 cell line. Luteolin significantly reduced POP-induced adipocyte formation at 2, 5 and 10 µM, and lipid accumulation at 10 µM. Interestingly, luteolin did not affect rosiglitazone induced adipo- and lipogenic effects, suggesting differences in mechanisms of action. In conclusion, this in vitro study shows that dietary polyphenols such as luteolin may protect against POP induced adipo- and lipogenic effects.


Subject(s)
Environmental Pollutants , Hydrocarbons, Chlorinated , Pesticides , Polychlorinated Biphenyls , Animals , Mice , Humans , Adipogenesis , 3T3-L1 Cells , Persistent Organic Pollutants , Luteolin/pharmacology , Rosiglitazone , Polychlorinated Biphenyls/analysis , Environmental Pollutants/analysis , Pesticides/analysis , Lipids , Halogenated Diphenyl Ethers/analysis
2.
Environ Int ; 132: 105083, 2019 11.
Article in English | MEDLINE | ID: mdl-31470217

ABSTRACT

INTRODUCTION: Human exposure to persistent organic pollutants (POPs) has been linked to genitourinary health-related conditions such as decreased sperm quality, hypospadias, and prostate cancer (PCa). Conventional risk assessment of POPs focuses on individual compounds. However, in real life, individuals are exposed to many compounds simultaneously. This might lead to combinatorial effects whereby the global effect of the mixture is different from the effect of the single elements or subgroups. POP mixtures may act as endocrine disruptors via the androgen receptor (AR) and potentially contribute to PCa development. AIM: To determine the endocrine disrupting activity of a POP mixture and sub-mixtures based upon exposure levels detected in a human Scandinavian population, on AR transactivation and translocation in vitro. MATERIALS AND METHODS: The Total POP mixture combined 29 chemicals modelled on the exposure profile of a Scandinavian population and 6 sub-mixtures: brominated (Br), chlorinated (Cl), Cl + Br, perfluorinated (PFAA), PFAA + Br, PFAA + Cl, ranging from 1/10× to 500× relative to what is found in human blood. Transactivation was measured by reporter gene assay (RGA) and translocation activity was measured by high content analysis (HCA), each using stably transfected AR model cell lines. RESULTS: No agonist activity in terms of transactivation and translocation was detected for any POP mixtures. In the presence of testosterone the Cl + Br mixture at 100× and 500× blood level antagonised AR transactivation, whereas the PFAA mixture at blood level increased AR transactivation (P < 0.05). In the presence of testosterone the Cl and PFAA + Br mixtures at 1/10×, 1×, and 50× blood level antagonised AR translocation (P < 0.05). CONCLUSION: Taken together, some combinations of POP mixtures can interfere with AR translocation. However, in the transactivation assay, these combinations did not affect gene transactivation. Other POP combinations were identified here as modulators of AR-induced gene transactivation without affecting AR translocation. Thus, to fully evaluate the effect of environmental toxins on AR signalling, both types of assays need to be applied.


Subject(s)
Androgen Receptor Antagonists/blood , Endocrine Disruptors/blood , Environmental Pollutants/blood , Environmental Pollutants/toxicity , Receptors, Androgen , Transcriptional Activation/drug effects , Androgen Receptor Antagonists/toxicity , Cells, Cultured , Endocrine Disruptors/toxicity , Genes, Reporter , Humans , Testosterone/pharmacology , Translocation, Genetic/drug effects
3.
Chemosphere ; 214: 534-542, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30278405

ABSTRACT

A multitude of cancer types, including breast, testicular, liver and colorectal cancer, have associations with exposure to Persistent Organic Pollutants (POPs). The present study aimed to investigate whether a mixture of POPs could affect intestinal tumorigenesis in the A/J Min/+ mouse, a model for human colorectal cancer (CRC). Pollutants were selected for their presence in Scandinavian food products and the mixture was designed based on defined human estimated daily intake levels. Mice were exposed through the diet, at control, low and high mixture concentrations, for 10 weeks. In a separate experiment, mice also received one subcutaneous injection of Azoxymethane (AOM) to explore whether this carcinogenic compound influenced the effect of the POPs. Intestinal tumorigenesis was examined by surface microscopy and histopathology. Moderate and dose-dependent increases in tumorigenesis were observed after dietary POP exposure. The AOM treatment alone stimulated the growth of colonic lesions, but did not increase the formation of new lesions. Combined AOM treatment and POP exposure demonstrated a synergistic effect on lesion formation in the colon, and to a lesser extent in the small intestine. This synergy was also evident by an increased number of malignant colonic tumors (carcinomas). In conclusion, the study shows that a mixture of POPs interacted synergistically with a known carcinogen (AOM), causing increased intestinal tumorigenesis in the A/J Min/+ mouse model.


Subject(s)
Azoxymethane/toxicity , Carcinogenesis/pathology , Colonic Neoplasms/pathology , Drug Synergism , Environmental Pollutants/toxicity , Intestines/pathology , Organic Chemicals/chemistry , Animals , Carcinogenesis/chemically induced , Carcinogens/toxicity , Colonic Neoplasms/chemically induced , Diet/adverse effects , Disease Models, Animal , Female , Intestines/drug effects , Liver/drug effects , Liver/pathology , Male , Mice , Mice, Inbred A
4.
Food Chem Toxicol ; 49(9): 2328-35, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21722693

ABSTRACT

Crude cod liver oil and liver oil supplements are consumed as a source of vitamin A, D and polyunsaturated fatty acids; during winter and early pregnancy. Crude cod liver oil however constitutes a considerable source of persistent organic pollutants (POPs). This paper aimed at characterizing and quantifying the influence of POP mixtures extracted from three different steps in the cod liver oil industrial process on hormone production and the expression of steroidogenesis-related genes in H295R cells. Exposure to extracts from crude cod liver oil and from its industrial waste increased progesterone (P4), cortisol (Cort), testosterone (T) and estradiol (E2) production; and among others, the expression of MC2R, CYP11B1 and HSD3B2 genes. Observed effects after exposure to pharmaceutical cod liver oil extract were considerably lower. The type of effects on gene expression and hormone production were similar to those induced by forskolin and PCBs, the latter being the major contaminants within the extracts. Additional research is required to further unveil the mechanisms behind the observed steroidogenic effects and to assess whether the potential risk might outweigh the potential benefits of crude and processed cod liver oil consumption.


Subject(s)
Cod Liver Oil/chemistry , Steroids/biosynthesis , Water Pollutants, Chemical/pharmacology , Animals , Base Sequence , Cell Line , DNA Primers , Gas Chromatography-Mass Spectrometry , Real-Time Polymerase Chain Reaction , Water Pollutants, Chemical/isolation & purification
5.
Acta Neurol Scand Suppl ; (189): 14-21, 2009.
Article in English | MEDLINE | ID: mdl-19566492

ABSTRACT

OBJECTIVES: To better understand the interaction of antiepileptic drugs and production of sex hormones, possible effects of valproate (VPA), levetiracetam (LEV) and carbamazepine (CBZ) on steroidogenesis were investigated in the human adrenal carcinoma cell line H295R. MATERIALS AND METHODS: H295R cells were exposed to different concentrations of VPA, LEV or CBZ for 48 h. Sex hormone concentrations and mRNA expression levels were analyzed via radioimmunoassay and quantitative real time (RT)-PCR, respectively. RESULTS: In VPA-exposed cells estradiol levels decreased in a dose-dependent manner, while testosterone and progesterone levels were unaffected. Expression of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGR), steroidogenic acute regulatory protein (StAR), CYP11a, CYP17, CYP21, 3betaHSD2, 17betaHSD1 was downregulated and expression of CYP11beta2 was upregulated. No effect on sex hormone production was observed under influence of LEV or CBZ. Expression of StAR, CYP17, CYP19 and 3betaHSD2 was downregulated in LEV-exposed cells, and expression of HMGR, CYP11beta2 and CYP17 was downregulated in CBZ-exposed cells. CONCLUSIONS: VPA exposure resulted in a decrease in estradiol levels and a general downregulation of expression of genes encoding for enzymes early in steroidogenesis. No consistent changes were seen with LEV or CBZ exposure.


Subject(s)
Anticonvulsants/pharmacology , Steroids/metabolism , Carbamazepine/pharmacology , Cell Line, Tumor , Cells, Cultured , Dose-Response Relationship, Drug , Down-Regulation , Endocrine Disruptors/pharmacology , Estradiol/metabolism , Humans , Hydroxymethylglutaryl CoA Reductases/genetics , Levetiracetam , Phosphoproteins/genetics , Piracetam/analogs & derivatives , Piracetam/pharmacology , Progesterone/metabolism , Radioimmunoassay , Reverse Transcriptase Polymerase Chain Reaction , Steroid Hydroxylases/genetics , Testosterone/metabolism , Valproic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...